Abstract:BackgroundPoor immunogenicity and extensive immunosuppressive T-cell infiltration in the tumor immune microenvironment (TIME) have been identified as potential barriers to immunotherapy success in "immune-cold" breast cancers. Thus, it is crucial to identify biomarkers that can predict immunotherapy efficacy. Protein tyrosine phosphatase receptor type O (PTPRO) regulates multiple kinases and pathways and has been implied to play a regulatory role in immune cell infiltration in various cancers. MethodsESTIMATE and single-sample gene set enrichment analysis (ssGSEA) were performed to uncover the TIME landscape. The correlation analysis of PTPRO and immune infiltration was performed to characterize the immune features of PTPRO. Univariate and multivariate Cox analyses were applied to determine the prognostic value of various variables and construct the PTPRO-related CD8(+) T-cell signatures (PTSs). The Kaplan-Meier curve and the receiver operating characteristic (ROC) curve were used to estimate the performance of PTS in assessing prognosis and immunotherapy response in multiple validation datasets. ResultsHigh PTPRO expression was related to high infiltration levels of CD8(+) T cells, as well as macrophages, activated dendritic cells (aDCs), tumor-infiltrating lymphocytes (TILs), and Th1 cells. Given the critical role of CD8(+) T cells in the TIME, we focused on the impact of PTPRO expression on CD8(+) T-cell infiltration. The prognostic PTS was then constructed using the TCGA training dataset. Further analysis showed that the PTS exhibited favorable prognostic performance in multiple validation datasets. Of note, the PTS could accurately predict the response to immune checkpoint inhibitors (ICIs). ConclusionPTPRO significantly impacts CD8(+) T-cell infiltration in breast cancer, suggesting a potential role of immunomodulation. PTPRO-based PTS provides a new immune cell paradigm for prognosis, which is valuable for immunotherapy decisions in cancer patients.

Regulatory Functions of Protein Tyrosine Phosphatase Receptor Type O in Immune Cells

The Pathophysiological Roles and Regulatory Mechanism of Retinoic Acid Receptor-related Orphan Receptors

PTPRO is a Therapeutic Target and Correlated with Immune Infiltrates in Pancreatic Cancer.

Recent Developments in the Role of Protein Tyrosine Phosphatase 1B (PTP1B) as a Regulator of Immune Cell Signalling in Health and Disease

Protein Tyrosine Phosphatase PTPRO Signaling Couples Metabolic States to Control the Development of Granulocyte Progenitor Cells

Tumor-Derived Exosomal Protein Tyrosine Phosphatase Receptor Type O Polarizes Macrophage to Suppress Breast Tumor Cell Invasion and Migration

Subcellular Localization of Intracellular Protein Tyrosine Phosphatases in T Cells

The Structure, Function and Regulation of Protein Tyrosine Phosphatase Receptor Type J and its Role in Diseases

T Cell Protein Tyrosine Phosphatase in Osteoimmunology

Immunotherapeutic implications of negative regulation by protein tyrosine phosphatases in T cells: the emerging cases of PTP1B and TCPTP

Protein tyrosine phosphatase with proline-glutamine-serine-threonine-rich motifs negatively regulates TLR-triggered innate responses by selectively inhibiting IκB kinase β/NF-κB activation.

Protein Phosphatase 2a (Pp2a) Is Essential For Cd8+T Cell Mediated Anti-Tumor Immunity

PTPRO Plays a Dual Role in Hepatic Ischemia Reperfusion Injury Through Feedback Activation of NF-κB

PTPROt Maintains T Cell Immunity in the Microenvironment of Hepatocellular Carcinoma.

Protein Tyrosine Phosphatase Receptor Type O Expression in the Tumor Niche Correlates with Reduced Tumor Growth, Angiogenesis, Circulating Tumor Cells and Metastasis of Breast Cancer

Advance in regulatory mechanism research of protein tyrosine phosphatases

Protein tyrosine phosphatase PTPRO represses lung adenocarcinoma progression by inducing mitochondria-dependent apoptosis and restraining tumor metastasis

Protein tyrosine phosphatase 1B is a regulator of the interleukin-10-induced transcriptional program in macrophages.

Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family

Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages.

PTPRO-related CD8(+) T-cell signatures predict prognosis and immunotherapy response in patients with breast cancer